Doshi Mansi, Parbat Minesh, Paudyal Vibhu, Marriott John
Medicines Optimisation Support and Services Development, Mumbai & Vadodara, India.
School of Pharmacy, University of Birmingham, Birmingham, B15 2TT, UK.
J Pharm Policy Pract. 2022 Mar 20;15(1):22. doi: 10.1186/s40545-022-00416-0.
Harm with inappropriate and irrational use of medications is a global challenge. The need for and patient access to medicines optimisation services is apparent globally and amplified in India due to multiple reasons. Clinical pharmacists are ideally placed to promote patient safety with medicines use optimisation and other pharmaceutical care services through appropriate legislative, policy, and compensation mechanisms to achieve optimal patient outcomes. The need is for a move at a global level, an enabling organisational structure at Pharmacy Councils and in practice regulations, particularly in countries where clinical roles are still in infancy. This narrative describes the current status and future needs for development of medicines optimisation services across sectors through regulatory and organisational reforms at the Pharmacy Council of India with additional registration, continuing professional development, renewal and licensing requirements for clinical pharmacists to respond to patient and societal needs in India.
药物使用不当和不合理造成的危害是一项全球性挑战。在全球范围内，对药物优化服务的需求以及患者获得此类服务的机会都很明显，而在印度，由于多种原因，这种需求更为突出。临床药师处于理想位置，可通过适当的立法、政策和补偿机制，促进药物使用优化及其他药学服务的患者安全，以实现最佳患者治疗效果。需要在全球层面采取行动，在药学委员会以及实践法规方面建立有利的组织结构，特别是在临床角色仍处于起步阶段的国家。本叙述描述了通过印度药学委员会的监管和组织改革，跨部门开展药物优化服务的现状和未来发展需求，包括对临床药师的额外注册、持续专业发展、续期和许可要求，以满足印度患者和社会的需求。
